Discontinuation report LIORESAL INTRATHECAL 2MG/ML
| Report ID | 201573 |
| Drug Identification Number | 02131064 |
| Brand name | LIORESAL INTRATHECAL 2MG/ML |
| Common or Proper name | LIORESAL INTR 10MG/5ML 1X5AMPS |
| Company Name | NOVARTIS PHARMACEUTICALS CANADA INC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | BACLOFEN |
| Strength(s) | 2MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRATHECAL INTRATHECAL |
| Packaging size | 1 x 5 amps |
| ATC code | M03BX |
| ATC description | MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | 2023-08-31 |
| Actual discontinuation date | 2023-09-01 |
| Remaining supply date | 2024-02-28 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 700 RUE SAINT-HUBERT MONTREAL, QUEBEC CANADA H2Y 0C1 |
| Company contact information | customer.relations@novartis.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2023-09-19 | French | Compare |
| v3 | 2023-09-19 | English | Compare |
| v2 | 2023-08-10 | French | Compare |
| v1 | 2023-08-10 | English | Compare |
Showing 1 to 4 of 4